Articles tagged with Type 2 Diabetes
Pharmac Expands Access to Type 2 Diabetes Medicines for Over 30,000 Patients
1 week ago | 112 viewsAssociate Health Minister David Seymour welcomes Pharmac’s decision to expand access to type 2 diabetes medicines based on clinical need, benefiting over 30,000 patients regardless of ethnicity. From 1 September, medicines like empagliflozin and liraglutide will be funded for anyone with high blood sugar despite other treatments, removing previous restrictions related to cardiovascular or renal conditions. This change, supported by community feedback and a new supplier agreement, aims to improve health outcomes, reduce complications, and optimize health budget efficiency.
Tags: David Seymour Pharmac type 2 diabetes empagliflozin metformin liraglutide dulaglutide New Zealand health access diabetes medicinesPharmac Proposes Wider Access to Type 2 Diabetes Medicines Based on Need
3 months ago | 632 viewsAssociate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to expand funding for three type 2 diabetes medicines by removing ethnicity-based criteria and lowering cardiovascular risk thresholds, aiming to improve access based on clinical need. If approved, the changes could benefit up to 23,000 more people over five years, enhancing early treatment to reduce complications and hospital admissions. This initiative aligns with the Government’s broader commitment to equitable, needs-based healthcare and increased health system funding to improve outcomes for all New Zealanders.
Tags: David Seymour Simeon Brown Pharmac type 2 diabetes empagliflozin liraglutide dulaglutide New Zealand health system Government